コーパス検索結果 (1語後でソート)
通し番号をクリックするとPubMedの該当ページを表示します
1 was immunized (Mycobacterium tuberculosis or Candida albicans).
2 l as with heat-inactivated and viable fungi (Candida albicans).
3 d no significant effect after challenge with Candida albicans.
4 equired for clearance of the fungal pathogen Candida albicans.
5 ingle Dig1 orthologue in the fungal pathogen Candida albicans.
6 lucans on the surface of the fungal pathogen Candida albicans.
7 s to cell wall stress in the fungal pathogen Candida albicans.
8 irulence factor of the human fungal pathogen Candida albicans.
9 antarum and the opportunistic human pathogen Candida albicans.
10 rium oxysporum, Saccharomyces cerevisiae and Candida albicans.
11 athogenesis of many fungal pathogens such as Candida albicans.
12 ith DNA repeats in the human fungal pathogen Candida albicans.
13 of temperature stress in the fungal pathogen Candida albicans.
14 mmune responses to Aspergillus fumigatus and Candida albicans.
15 peptide toxin in the opportunistic pathogen Candida albicans.
16 rived dendritic cells (moDCs) that presented Candida albicans.
17 ose residues that cap the glycan produced by Candida albicans.
18 a transition in the human pathogenic fungus Candida albicans.
19 lysins have weak antifungal activity against Candida albicans.
20 lity and provided partial protection against Candida albicans.
21 ion to Cu taken by the human fungal pathogen Candida albicans.
22 li) bacteria, as well as on pathogenic fungi Candida albicans.
23 e to NLRP3 stimuli, including infection with Candida albicans.
24 helper T cells in controlling infection with Candida albicans.
25 toward aneuploidy-based azole resistance in Candida albicans.
26 al infection caused by the commensal microbe Candida albicans.
27 n mentagrophytes, Aspergillus fumigatus, and Candida albicans.
28 n yeast species identified in all groups was Candida albicans.
29 n different cellular systems stimulated with Candida albicans.
30 il recruitment during invasion of the CNS by Candida albicans.
31 ganisms including the human fungal pathogen, Candida albicans.
32 of Hsp90 in a leading human fungal pathogen, Candida albicans.
33 ning and integration into a neutral locus in Candida albicans.
34 from the most common human fungal pathogen, Candida albicans.
35 e homophilic adhesion in the fungal pathogen Candida albicans.
36 with a lethal dose of the pathogenic fungus Candida albicans.
38 is essential for GlcNAc signalling (NGS1) in Candida albicans, a commensal and pathogenic yeast of hu
39 e for IL-17 in protection against the fungus Candida albicans, a commensal microbe of the human oral
40 cus faecalis, a Gram-positive bacterium, and Candida albicans, a fungus, occupy overlapping niches as
45 revisit this concept from the perspective of Candida albicans, a microbial pathogen uniquely adapted
46 the N-terminal domain of Tps2 (Tps2NTD) from Candida albicans, a transition-state complex of the Tps2
50 e Oma1 ortholog in the human fungal pathogen Candida albicans also alters TOR signaling and, unexpect
51 e separase homologue Esp1p in the ascomycete Candida albicans, an important pathogen of humans, is es
52 trated that medically relevant fungi such as Candida albicans and Aspergillus fumigatus also form bio
56 formed stable homotetramers, the mtSSBs from Candida albicans and Candida parapsilosis formed stable
57 y against the opportunistic fungal pathogens Candida albicans and Cryptococcus neoformans However, th
59 iroscytalin showed moderate activity against Candida albicans and good activity against an export-def
64 erimental whole-genome mutation screening in Candida albicans and Pseudomonas aureginosa genomes, whi
66 rthologues from Saccharomyces cerevisiae and Candida albicans and show that under nitrogen-sufficient
67 l IAI and demonstrated that coinfection with Candida albicans and Staphylococcus aureus (C. albicans/
68 had recurrent mucocutaneous infections with Candida albicans and Staphylococcus aureus and chronic i
69 tin-1, mannose, and Toll-like receptors with Candida albicans and Staphylococcus epidermidis was 2.5-
74 s, whereas Th17 cells are protective against Candida albicans and to a lesser degree Staphylococcus a
76 (methicillin-resistant S. aureus (MRSA) and Candida albicans) and standard (Pseudomonas aeruginosa 1
77 h responses against Clostridium perfringens, Candida albicans, and Bacteroides vulgatus were also cou
78 module subunits of Saccharomyces cerevisiae, Candida albicans, and Candida dubliniensis Mediator, whi
79 aphylococcus aureus, Listeria monocytogenes, Candida albicans, and Candida parapsilosis isolates were
80 ease in phagocytosis of complement-opsonized Candida albicans, and decreased production of TNF-alpha
81 ey pattern-recognition receptors for sensing Candida albicans, and their downstream kinase SYK, thus
83 efflux in highly azole-resistant strains of Candida albicans, another human fungal pathogen, increas
86 y childhood caries, Streptococcus mutans and Candida albicans are often co-isolated from carious lesi
89 d by the opportunistic human fungal pathogen Candida albicans Aside from its primary function of bloc
90 t fungal infections, caused most commonly by Candida albicans, Aspergillus fumigatus and Cryptococcus
91 Here we measured ASE in the diploid yeast Candida albicans at both the transcriptional and transla
93 is study evaluated the antifungal effects on Candida albicans ATCC90028, the cytotoxicity toward huma
94 substrate and metal ions reveal that, unlike Candida albicans, binding of substrate to vDHBPS induces
97 proteins associated with several in vivo rat Candida albicans biofilms, including those from vascular
99 alized to the nucleus of Pichia pastoris and Candida albicans but is cytoplasmic in Saccharomyces cer
100 , a stronger cytokine response compared with Candida albicans, but a lower macrophage lysis capacity.
101 tly lost in the Metschnikowiaceae, including Candida albicans, but became more complex in the Sacchar
104 combinations, including the human pathogens Candida albicans, C. glabrata and Cryptococcus neoforman
106 rom Schizosaccharomyces pombe (Sp-Hsp104) or Candida albicans (Ca-Hsp104) also trimmed and cured the
109 ad-spectrum synergistic interactions against Candida albicans, Candida auris, Cryptococcus neoformans
111 ecificity of 98.9% (95% CI, 98.3%-99.4%) for Candida albicans/Candida tropicalis, 99.3% (95% CI, 98.7
112 ely colonized by pathobiont microbes such as Candida albicans, capable of invasive disseminated infec
116 his research was to evaluate the adhesion of Candida albicans cells onto PMMA surfaces by employing a
119 lla pneumophila, Streptococcus pneumonia and Candida albicans cleaved the N-terminus of immunoglobuli
121 ceipt of broad-spectrum antibiotics enhances Candida albicans colonization of the GI tract, a risk fa
123 enhanced in patients with CF colonized with Candida albicans compared with that in noncolonized pati
125 human vaginal epithelium, and to the fungus Candida albicans Complementary crystallographic and biop
126 nous SHIP-1 relocated to live or heat-killed Candida albicans-containing phagosomes in a Dectin-1-dep
127 CD82 and Dectin-1 on the plasma membrane of Candida albicans-containing phagosomes independent of ph
129 man fungal pathogens (Aspergillus fumigatus, Candida albicans, Cryptococcus neoformans and Coccidioid
132 cell responses against Escherichia coli and Candida albicans displayed microbe-specific polyfunction
135 prevented the death of the pathogenic yeast Candida albicans during exposure to fluconazole plus a c
136 The genome of the meiosis-defective pathogen Candida albicans encodes an Rme1 homolog that is part of
137 sponses to host cells in the fungal pathogen Candida albicans Eukaryotic Target of Rapamycin complex
141 Here, we reveal that the fungal pathogen Candida albicans exploits diverse host-associated signal
142 cently, we reported that the fungal pathogen Candida albicans expresses a novel copper-only SOD, know
145 lecular-based assay for the detection of the Candida albicans FKS1 gene mutations responsible for res
148 The plasma membrane of the fungal pathogen Candida albicans forms a protective barrier that also me
149 nsition of the opportunistic fungal pathogen Candida albicans from budding to hyphal growth has been
150 two species of Candida (Cornus glabrata and Candida albicans) from Candida-spiked blood samples.
151 e capacity of peach DMSO extracts to inhibit Candida albicans growth was more pronounced, especially,
154 fection, and opportunistic pathogens such as Candida albicans have evolved complex circuitry to sense
156 SOD5 from the opportunistic fungal pathogen Candida albicans have revealed that the active-site stru
157 organisms in the oral cavity, while TM7x and Candida albicans have served as crucial paradigms for CP
158 sin is a cytolytic peptide toxin secreted by Candida albicans hyphae and has significantly advanced o
159 d NETs in response to fungal beta-glucan and Candida albicans hyphae when presented with extracellula
160 e oral mucosa caused by the commensal fungus Candida albicans IL-17R signaling is essential to preven
163 ons of amphotericin B after inoculation with Candida albicans in light-exposed and light-protected co
165 ether the recently observed sensitization to Candida albicans in patients with EoE is owing to pre-ex
166 were evaluated against the pathogenic yeast Candida albicans in the absence or presence of exogenous
167 eptococcus mutans, Streptococcus oralis, and Candida albicans in the saliva from mothers and their in
168 ns in the most common human fungal pathogen: Candida albicans In this organism, the histone deacetyla
170 cterium, Pseudomonas aeruginosa and a yeast, Candida albicans, induce the resistance of the latter to
172 eles: R70W and Q289* for the 3 patients with Candida albicans-induced meningoencephalitis, R35Q for t
173 ononuclear cells, these molecules suppressed Candida albicans-induced production of the cancer-promot
174 n pathogenic fungi Aspergillus fumigatus and Candida albicans induces a distinct subset of neutrophil
176 uently, dnTCF4 mice were more susceptible to Candida albicans infection and more sensitive to 5-fluor
177 results in enhanced defense against systemic Candida albicans infection and prolonged host survival.
178 myeloid cells show higher susceptibility to Candida albicans infection due to impairment in neutroph
179 enting the corneal innate immune response to Candida albicans infection in an animal model of fungal
182 o demonstrated in a murine model of systemic Candida albicans infection with a significant fungal loa
183 e than wild-type control mice in response to Candida albicans infection, and the expression of JNK1 i
185 e showed enhanced resistance to disseminated Candida albicans infection, which was reversed in an Il1
191 imental mouse model of Staphylococcus aureus-Candida albicans intra-abdominal infection results in ap
206 mmune response, and yet the commensal fungus Candida albicans is able to colonize immuno competent in
209 recent study shows that the commensal fungus Candida albicans is an inducer of differentiation of hum
219 ith its mammalian host, the pathogenic yeast Candida albicans is exposed to a range of stresses such
234 some complement of the human fungal pathogen Candida albicans is unusually unstable, suggesting that
235 erant fungi, including filamentous fungi and Candida albicans, is associated with poor lung function
236 ogenicity of the clinically important yeast, Candida albicans, is dependent on robust responses to ho
239 PE produced from Escherichia coli membranes, Candida albicans mitochondria, or HeLa cell mitochondria
243 NOPE1 encodes a functional homologue of the Candida albicans N-acetylglucosamine (GlcNAc) transporte
244 e most common fungal species identified were Candida albicans (n = 85), Candida glabrata (n = 63), an
245 ly important differences with human NatA and Candida albicans NatB, resolves key hNatB protein determ
246 e ability of these cells to kill/phagocytose Candida albicans or Escherichia coli cells both ex vivo
247 tears and protected the eye from pathogenic Candida albicans or Pseudomonas aeruginosa infection.
249 d with lipopolysaccharide (LPS), heat-killed Candida albicans, or anti-CD3/anti-CD28 antibodies.
251 e in which the loss of an ABC transporter in Candida albicans, orf19.4531 (previously named ROA1), in
252 growth in the opportunistic fungal pathogen Candida albicans Our results suggest that HHK3 regulates
254 rials, contains a recombinant version of the Candida albicans rAls3 N-terminus protein (rAls3p-N) in
255 mon causes of invasive mycotic disease, with Candida albicans reigning as the leading cause of invasi
256 ha-mannoside, found in Saccharopolyspora and Candida albicans, respectively, induced the activation o
258 common disease affecting women; however, how Candida albicans shift from commensalism towards a patho
259 clusively on immune stimulation, including a Candida albicans-specific master regulator at the CR1 lo
262 y (EIS) that allows multiplexed detection of Candida albicans, Streptococcus agalactiae and Chlamydia
264 us oralis forms robust mucosal biofilms with Candida albicans that have increased pathogenic potentia
265 tein histatin 5 (Hst 5) is fungicidal toward Candida albicans, the causative agent of oropharyngeal c
268 Surprisingly, we found that the genome of Candida albicans, the predominant human fungal pathogen,
269 ulates virulence of pathogenic fungi such as Candida albicans, the underlying mechanisms have remaine
270 hin a population of macrophages encountering Candida albicans, there are distinct host-pathogen traje
271 e of circulating Cryptococcus neoformans and Candida albicans, thereby reducing fungal dissemination
272 ability of the fungal opportunistic pathogen Candida albicans to adhere to denture material and invad
273 e circuitry that enables the fungal pathogen Candida albicans to couple cell cycle dynamics with resp
275 osamine (GlcNAc), induce the fungal pathogen Candida albicans to switch from budding to hyphal growth
277 and long-lasting antifungal effects against Candida albicans to the PMMA resin, and it has low toxic
280 rms expressed by Cryptococcus neoformans and Candida albicans, two pathogenic fungi of major clinical
283 otocol for CRISPR-Cas9-based manipulation in Candida albicans using a modified gene-drive-based strat
286 s, and rewired transcription subnetworks for Candida albicans versus Saccharomyces cerevisiae, agains
287 gal polyketide with in vivo efficacy against Candida albicans, was discovered using LCMS-based metabo
288 a mouse model of KD (induced by a cell wall Candida albicans water-soluble fraction [CAWS]), we iden
289 a model of intradermal footpad injection of Candida albicans, we observed that inflammation as measu
290 ntage of the minimal MT nucleation system of Candida albicans, we reconstituted the interactions of M
291 injection of the water-soluble component of Candida albicans, we therefore undertook a mechanistic s
292 ive (Escherichia coli) bacteria and a fungi (Candida albicans) were examined; which showed good antib
294 e of Trl1 KIN-CPD from the pathogenic fungus Candida albicans, which adopts an extended conformation
295 analysis of the polymorphic fungal pathogen Candida albicans, which contains one of the smallest kno
296 epigenetic states, "white" and "opaque." In Candida albicans, white cells are essentially sterile, w
297 nase domain of Trl1 from the fungal pathogen Candida albicans with GDP and Mg2+ in the active site.
300 rofoundly resistant to systemic infection by Candida albicans, with resistance characterized by enhan